# Clinical Trial of Autologous CD19 CAR-T Cells (CNCT19) Therapy for Advanced Hepatocellular Carcinoma

> **NCT06676982** · PHASE1 · RECRUITING · sponsor: **Zhejiang University** · enrollment: 12 (estimated)

## Conditions studied

- Advanced Hepatocellular Carcinoma

## Interventions

- **BIOLOGICAL:** anti-CD19 CAR-T

## Key facts

- **NCT ID:** NCT06676982
- **Lead sponsor:** Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-10
- **Primary completion:** 2026-07-30
- **Final completion:** 2026-08-31
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-12-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06676982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06676982, "Clinical Trial of Autologous CD19 CAR-T Cells (CNCT19) Therapy for Advanced Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT06676982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*